Literature DB >> 33383923

Urinary Volatile Organic Compound Analysis for the Diagnosis of Cancer: A Systematic Literature Review and Quality Assessment.

Qing Wen1, Piers Boshier1, Antonis Myridakis1, Ilaria Belluomo1, George B Hanna1.   

Abstract

The analysis of urinary volatile organic compounds (VOCs) is a promising field of research with the potential to discover new biomarkers for cancer early detection. This systematic review aims to summarise the published literature concerning cancer-associated urinary VOCs. A systematic online literature search was conducted to identify studies reporting urinary VOC biomarkers of cancers in accordance with the recommendations of the Cochrane Library and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Thirteen studies comprising 1266 participants in total were included in the review. Studies reported urinary VOC profiles of five cancer subtypes: prostate cancer, gastrointestinal cancer, leukaemia/lymphoma, lung cancer, and bladder cancer. Forty-eight urinary VOCs belonging to eleven chemical classes were identified with high diagnostic performance. VOC profiles were distinctive for each cancer type with limited cross-over. The metabolic analysis suggested distinctive phenotypes for prostate and gastrointestinal cancers. The heterogenicity of study design, methodological and reporting quality may have contributed to inconsistencies between studies. Urinary VOC analysis has shown promising performance for non-invasive diagnosis of cancer. However, limitations in study design have resulted in inconsistencies between studies. These limitations are summarised and discussed in order to support future studies.

Entities:  

Keywords:  cancer early detection; mass spectrometry; urine; volatile organic compounds

Year:  2020        PMID: 33383923      PMCID: PMC7824454          DOI: 10.3390/metabo11010017

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  31 in total

1.  Global metabolic profiling procedures for urine using UPLC-MS.

Authors:  Elizabeth J Want; Ian D Wilson; Helen Gika; Georgios Theodoridis; Robert S Plumb; John Shockcor; Elaine Holmes; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-06       Impact factor: 13.491

Review 2.  VOC breath biomarkers in lung cancer.

Authors:  Yannick Saalberg; Marcus Wolff
Journal:  Clin Chim Acta       Date:  2016-05-21       Impact factor: 3.786

3.  Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.

Authors:  Wiktoria Struck-Lewicka; Marta Kordalewska; Renata Bujak; Arlette Yumba Mpanga; Marcin Markuszewski; Julia Jacyna; Marcin Matuszewski; Roman Kaliszan; Michał J Markuszewski
Journal:  J Pharm Biomed Anal       Date:  2015-01-06       Impact factor: 3.935

4.  Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers.

Authors:  Concetta Panebianco; Edgar Kelman; Kristel Vene; Domenica Gioffreda; Francesca Tavano; Raivo Vilu; Fulvia Terracciano; Illar Pata; Kaarel Adamberg; Angelo Andriulli; Valerio Pazienza
Journal:  Clin Chem Lab Med       Date:  2017-11-27       Impact factor: 3.694

5.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.

Authors:  G Peng; M Hakim; Y Y Broza; S Billan; R Abdah-Bortnyak; A Kuten; U Tisch; H Haick
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

6.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.

Authors:  Olaf Beckonert; Hector C Keun; Timothy M D Ebbels; Jacob Bundy; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

8.  Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.

Authors:  Ramesh P Arasaradnam; Michael J McFarlane; Courtenay Ryan-Fisher; Erik Westenbrink; Phoebe Hodges; Paula Hodges; Matthew G Thomas; Samantha Chambers; Nicola O'Connell; Catherine Bailey; Christopher Harmston; Chuka U Nwokolo; Karna D Bardhan; James A Covington
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer.

Authors:  S R Markar; B Brodie; S-T Chin; A Romano; D Spalding; G B Hanna
Journal:  Br J Surg       Date:  2018-07-18       Impact factor: 6.939

10.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis.

Authors:  Jasmine Chong; Othman Soufan; Carin Li; Iurie Caraus; Shuzhao Li; Guillaume Bourque; David S Wishart; Jianguo Xia
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

View more
  9 in total

Review 1.  Emerging Approaches to Complement Low-Dose Computerized Tomography for Lung Cancer Screening: A Narrative Review.

Authors:  Bradley Maller; Tawee Tanvetyanon
Journal:  Cureus       Date:  2022-07-26

2.  Green Phosphorene as a Promising Biosensor for Detection of Furan and p-Xylene as Biomarkers of Disease: A DFT Study.

Authors:  Aref Aasi; Erfan Aasi; Sadegh Mehdi Aghaei; Balaji Panchapakesan
Journal:  Sensors (Basel)       Date:  2022-04-21       Impact factor: 3.847

3.  Urinary Volatile Organic Compound Testing in Fast-Track Patients with Suspected Colorectal Cancer.

Authors:  Caroline E Boulind; Oliver Gould; Ben de Lacy Costello; Joanna Allison; Paul White; Paul Ewings; Alfian N Wicaksono; Nathan J Curtis; Anne Pullyblank; David Jayne; James A Covington; Norman Ratcliffe; Claire Turner; Nader K Francis
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

4.  Optimization of training and measurement protocol for eNose analysis of urine headspace aimed at prostate cancer diagnosis.

Authors:  Laura Capelli; Carmen Bax; Fabio Grizzi; Gianluigi Taverna
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

5.  Volatile organic compounds as a potential screening tool for neoplasm of the digestive system: a meta-analysis.

Authors:  Lili Zhong; Yinlong Zhao; Lixing Wang; Junan Li; Xiaoliang Xiong; Tingting Hao; Chao Zhang; Zhao Gao
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

6.  Assessing volatile organic compounds exposure and prostate-specific antigen: National Health and Nutrition Examination Survey, 2001-2010.

Authors:  Chengcheng Wei; Yumao Chen; Yu Yang; Dong Ni; Yu Huang; Miao Wang; Xiong Yang; Zhaohui Chen
Journal:  Front Public Health       Date:  2022-07-29

7.  A new detection method for canine and feline cancer using the olfactory system of nematodes.

Authors:  Toshimi Sugimoto; Yozo Okuda; Ayaka Shima; Natsuko Sugiura; Nobuaki Kondo; Genki Ishihara; Takaaki Hirotsu; Eric di Luccio
Journal:  Biochem Biophys Rep       Date:  2022-09-05

8.  Urinary Volatomic Expression Pattern: Paving the Way for Identification of Potential Candidate Biosignatures for Lung Cancer.

Authors:  Khushman Taunk; Priscilla Porto-Figueira; Jorge A M Pereira; Ravindra Taware; Nattane Luíza da Costa; Rommel Barbosa; Srikanth Rapole; José S Câmara
Journal:  Metabolites       Date:  2022-01-04

9.  Volatile Organic Compound Profile Fingerprints Using DART-MS Shows Species-Specific Patterns in Fusarium Mycotoxin Producing Fungi.

Authors:  Mark Busman; Ethan Roberts; Robert H Proctor; Chris M Maragos
Journal:  J Fungi (Basel)       Date:  2021-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.